When Julie Kane’s infant son, Connor Okruhlica, needed a liver transplant in 1997, her family traveled from Kentucky to Omaha for the life-saving procedure. The family faced a difficult journey, but the kindness and generosity they experienced along the way left a lasting impact.
Previous attempts to treat Christine’s Chronic Lymphocytic Leukemia (CLL) had failed. She participated in a clinical trial and subsequently went through a CAR T-cell transplant at the NCI-designated Fred & Pamela Buffett Cancer Center.
The Fred & Pamela Buffett Cancer Center is a recognized leader in cellular therapies such as stem cell transplants, bone marrow transplants and CAR T-cell therapy, treatments that harness the body’s own cells to fight cancer.
Harlan High School basketball coach Mitch Osborn has been through a lot over the last decade. Not one but two kinds of cancer. Hundreds of visits to the Fred & Pamela Buffett Cancer Center for treatment.
Researchers are investigating a novel combination therapy that could offer hope for patients with recurrent high-grade glioma, a challenging form of brain cancer.
When the Nebraska Medicine Blood and Bone Marrow Transplant Program celebrated its 40th anniversary in 2023, Bruce Sheffield, MD, was there. Dr. Sheffield is one of the thousands of patients who have benefitted from the program’s success.
You’re about to leave the Nebraska Medicine website. The other site may collect information about your visit, including your IP address. Do you want to continue?